{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T03:05:21Z","timestamp":1790737521924,"version":"4.1.0"},"reference-count":29,"publisher":"Public Library of Science (PLoS)","issue":"12","license":[{"start":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T00:00:00Z","timestamp":1546214400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0902150"],"award-info":[{"award-number":["G0902150"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000278","name":"Department for International Development","doi-asserted-by":"publisher","award":["G0902150"],"award-info":[{"award-number":["G0902150"]}],"id":[{"id":"10.13039\/501100000278","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001713","name":"European and Developing Countries Clinical Trials Partnership","doi-asserted-by":"publisher","award":["G0902150"],"award-info":[{"award-number":["G0902150"]}],"id":[{"id":"10.13039\/501100001713","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"crossref","award":["G0902150"],"award-info":[{"award-number":["G0902150"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12023\/27"],"award-info":[{"award-number":["MC_UU_12023\/27"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"DOI":"10.1371\/journal.pone.0206907","type":"journal-article","created":{"date-parts":[[2018,12,31]],"date-time":"2018-12-31T18:38:21Z","timestamp":1546281501000},"page":"e0206907","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":17,"title":["Discontinuing cotrimoxazole preventive therapy in HIV-infected adults who are stable on antiretroviral treatment in Uganda (COSTOP): A randomised placebo controlled trial"],"prefix":"10.1371","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5771-5515","authenticated-orcid":true,"given":"Zacchaeus","family":"Anywaine","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronnie","family":"Kasirye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph Kayiira","family":"Lutaakome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Abaasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nunn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiner","family":"Grosskurth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paula","family":"Munderi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"name":"on behalf of the COSTOP research team","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"340","published-online":{"date-parts":[[2018,12,31]]},"reference":[{"key":"ref1","unstructured":"UNAIDS (2000) Provisional WHO\/UNAIDS Secretariate recommendations on the use of Cotrimoxazole prophylaxis in Adults and Children living with HIV\/AIDS in Africa. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/data.unaids.org\/publications\/irc-pub04\/recommendation_en.pdf\" xlink:type=\"simple\">http:\/\/data.unaids.org\/publications\/irc-pub04\/recommendation_en.pdf<\/ext-link>; Accessed 18th June 2018."},{"key":"ref2","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(98)07399-1","article-title":"Early chemoprophylaxis with trimethoprim-sulphamethoxazole for HIV-1-infected adults in Abidjan, C\u00f4te d&apos;Ivoire: a randomised trial","volume":"353","author":"X Anglaret","year":"1999","journal-title":"The Lancet"},{"key":"ref3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/01.qai.0000221679.14445.1b","article-title":"Feasibility and effectiveness of cotrimoxazole prophylaxis for HIV-1-infected adults attending an HIV\/AIDS clinic in Uganda","volume":"42","author":"C Watera","year":"2006","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref4","doi-asserted-by":"crossref","first-page":"e0131353","DOI":"10.1371\/journal.pone.0131353","article-title":"Trends in AIDS deaths, new infections and ART coverage in the top 30 countries with the highest AIDS mortality burden; 1990\u20132013","volume":"10","author":"R Granich","year":"2015","journal-title":"PloS One"},{"key":"ref5","doi-asserted-by":"crossref","first-page":"e33672","DOI":"10.1371\/journal.pone.0033672","article-title":"Cost effectiveness analysis of clinically driven versus routine laboratory monitoring of antiretroviral therapy in Uganda and Zimbabwe","volume":"7","author":"AM Lara","year":"2012","journal-title":"PLoS One"},{"key":"ref6","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1177\/135965350501000510","article-title":"Haematological changes in adults receiving a zidovudine-containing HAART regimen in combination with co-trimoxazole in C\u00f4te d\u2019Ivoire","volume":"10","author":"R Moh","year":"2005","journal-title":"Antivir Ther"},{"key":"ref7","doi-asserted-by":"crossref","first-page":"S254","DOI":"10.1007\/BF01643199","article-title":"Skin reactions to co-trimoxazole","volume":"15","author":"E Sch\u00f6pf","year":"1987","journal-title":"Infection"},{"key":"ref8","unstructured":"Guidelines for Prevention and Treatment of Opportunistic Infections in HIV-Infected Adults and Adolescents. Recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr58e324a1.htm\" xlink:type=\"simple\">https:\/\/www.cdc.gov\/mmwr\/preview\/mmwrhtml\/rr58e324a1.htm<\/ext-link>. Accessed 18th June 2018."},{"key":"ref9","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(01)06201-8","article-title":"Plasmodium falciparum crossresistance between trimethoprim and pyrimethamine","volume":"358","author":"JK Iyer","year":"2001","journal-title":"The Lancet"},{"key":"ref10","unstructured":"EACS European AIDS Clinical Society. Guidelines Version 9.0, October 2017. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html\" xlink:type=\"simple\">http:\/\/www.eacsociety.org\/guidelines\/eacs-guidelines\/eacs-guidelines.html<\/ext-link>. Accessed 18th June 2018."},{"key":"ref11","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1177\/2325957414535976","article-title":"Global policy review of recommendations on cotrimoxazole prophylaxis among people living with HIV","volume":"13","author":"S Gupta","year":"2014","journal-title":"Journal of the International Association of Providers of AIDS Care"},{"key":"ref12","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1097\/QAI.0b013e3181378ed2","article-title":"Lower early mortality rates among patients receiving antiretroviral treatment at clinics offering cotrimoxazole prophylaxis in Malawi","volume":"46","author":"D Lowrance","year":"2007","journal-title":"Journal of Acquired Immune Deficiency Syndromes"},{"key":"ref13","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1097\/QAD.0b013e32833ac6bc","article-title":"Reducing mortality with co-trimoxazole preventive therapy at initiation of antiretroviral therapy in South Africa","volume":"24","author":"CJ Hoffmann","year":"2010","journal-title":"AIDS"},{"key":"ref14","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/S0140-6736(10)60057-8","article-title":"Daily co-trimoxazole prophylaxis in severely immunosuppressed HIV-infected adults in Africa started on combination antiretroviral therapy: an observational analysis of the DART cohort","volume":"375","author":"A Walker","year":"2010","journal-title":"The Lancet"},{"key":"ref15","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1093\/cid\/cis013","article-title":"HIV-infected Ugandan adults taking antiretroviral therapy with CD4 counts&gt; 200 cells\/\u03bcL who discontinue cotrimoxazole prophylaxis have increased risk of malaria and diarrhea","volume":"54","author":"JD Campbell","year":"2012","journal-title":"Clinical Infectious Diseases"},{"key":"ref16","doi-asserted-by":"crossref","first-page":"e1001934","DOI":"10.1371\/journal.pmed.1001934","article-title":"Cotrimoxazole prophylaxis discontinuation among antiretroviral-treated HIV-1-infected adults in Kenya: a randomized non-inferiority trial","volume":"13","author":"CS Polyak","year":"2016","journal-title":"PLoS Medicine"},{"key":"ref17","unstructured":"WHO 2014. Guidelines on post-exposure prophylaxis for HIV and the use of co-trimoxazole prophylaxis for HIV-related infections among adults, adolescents and children. Recommendations for a public health approach\u2014December 2014 supplement to the 2013 consolidated ARV guidelines. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/arvs2013upplement_dec2014\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/arv2013\/arvs2013upplement_dec2014\/en\/<\/ext-link> Accessed 18th June 2018."},{"key":"ref18","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.cct.2015.05.015","article-title":"Safety of discontinuing cotrimoxazole prophylaxis among HIV infected adults on anti-retroviral therapy in Uganda (COSTOP trial): Design","volume":"43","author":"Z Anywaine","year":"2015","journal-title":"Contemporary Clinical Trials"},{"key":"ref19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1097\/QAD.0000000000000956","article-title":"Incidence of malaria by cotrimoxazole use in HIV-infected Ugandan adults on antiretroviral therapy: a randomised, placebo-controlled study","volume":"30","author":"RP Kasirye","year":"2016","journal-title":"AIDS"},{"key":"ref20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.conctc.2016.05.008","article-title":"Exit interviews administered to patients participating in the COSTOP placebo controlled randomised trial in Uganda","volume":"3","author":"A Nunn","year":"2016","journal-title":"Contemporary Clinical Trials Communications"},{"key":"ref21","unstructured":"WHO 2006. WHO case definitions of HIV for surveillance and revised clinical staging and immunological classification of HIV-related disease in adults and children. 7 August 2006. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/hiv\/pub\/guidelines\/hivstaging\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/hiv\/pub\/guidelines\/hivstaging\/en\/<\/ext-link>. Accessed 18th June 2018."},{"key":"ref22","unstructured":"U.S. Department of Health and Human Services, National Institutes of Health, National Institute of Allergy and Infectious Diseases, Division of AIDS. Division of AIDS Table for Grading the Severity of Adult and Pediatric Adverse Events, Version 1.0. [Updated August 2009]. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/rsc.tech-res.com\/docs\/defaultsource\/safety\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf\" xlink:type=\"simple\">http:\/\/rsc.tech-res.com\/docs\/defaultsource\/safety\/table_for_grading_severity_of_adult_pediatric_adverse_events.pdf<\/ext-link>. Accessed 18th June 2018."},{"key":"ref23","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/S0140-6736(09)62067-5","article-title":"Routine versus clinically driven laboratory monitoring of HIV antiretroviral therapy in Africa (DART): a randomised non-inferiority trial","volume":"375","author":"P WA Mugyenyi","year":"2010","journal-title":"The Lancet"},{"key":"ref24","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1046\/j.1472-8206.2003.00162.x","article-title":"The pros and cons of noninferiority trials","volume":"17","author":"SJ Pocock","year":"2003","journal-title":"Fundamental and Clinical Pharmacology"},{"key":"ref25","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/bjc.1976.220","article-title":"Design and analysis of randomized clinical trials requiring prolonged observation of each patient. I. Introduction and design","volume":"34","author":"R Peto","year":"1976","journal-title":"British journal of cancer"},{"key":"ref26","doi-asserted-by":"crossref","first-page":"e56916","DOI":"10.1371\/journal.pone.0056916","article-title":"Safety and efficacy of cotrimoxazole for treatment and prevention of Plasmodium falciparum malaria: a systematic review","volume":"8","author":"C NE Manyando","year":"2013","journal-title":"PLoS One"},{"key":"ref27","doi-asserted-by":"crossref","first-page":"320","DOI":"10.4269\/ajtmh.2008.79.320","article-title":"Does cotrimoxazole prophylaxis for the prevention of HIV-associated opportunistic infections select for resistant pathogens in Kenyan adults?","volume":"79","author":"MJ Hamel","year":"2008","journal-title":"The American Journal of Tropical Medicine and Hygiene"},{"key":"ref28","unstructured":"WHO 2015. Guidelines for treatment of malaria. Third edition. April 2015. Available from: <ext-link xmlns:xlink=\"http:\/\/www.w3.org\/1999\/xlink\" ext-link-type=\"uri\" xlink:href=\"http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/\" xlink:type=\"simple\">http:\/\/www.who.int\/malaria\/publications\/atoz\/9789241549127\/en\/<\/ext-link> Accessed 18th June 2018."},{"key":"ref29","doi-asserted-by":"crossref","first-page":"e137","DOI":"10.1016\/S2352-3018(15)00005-3","article-title":"Co-trimoxazole prophylaxis in adults, including pregnant women, with HIV: a systematic review and meta-analysis","volume":"2","author":"AB Suthar","year":"2015","journal-title":"The Lancet HIV"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/dx.plos.org\/10.1371\/journal.pone.0206907","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T11:47:07Z","timestamp":1662724027000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0206907"}},"subtitle":[],"editor":[{"given":"Richard John","family":"Lessells","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"editor"}]}],"short-title":[],"issued":{"date-parts":[[2018,12,31]]},"references-count":29,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2018,12,31]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0206907","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,12,31]]}}}